MeiraGTx Holdings (MGTX) EPS (Basic) Growth (1y) (2018 - 2025)
MeiraGTx Holdings (MGTX) EPS (Basic) Growth (1y) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 29.25% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 17,151.81% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 61.34% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -7.74% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 88.81% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 133.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 133.24% |
| Sep 30, 2025 | -13.66% |
| Jun 30, 2025 | 36.26% |
| Mar 31, 2025 | -58.54% |
| Dec 31, 2024 | -257.67% |
| Sep 30, 2024 | 26.22% |
| Jun 30, 2024 | -41.32% |
| Mar 31, 2024 | 48.89% |
| Dec 31, 2023 | 159.20% |
| Sep 30, 2023 | 10.81% |
| Jun 30, 2023 | 29.73% |
| Mar 31, 2023 | 10.51% |
| Dec 31, 2022 | -169.22% |
| Sep 30, 2022 | -42.04% |
| Jun 30, 2022 | -67.13% |
| Mar 31, 2022 | -29.90% |
| Dec 31, 2021 | 19.02% |
| Sep 30, 2021 | -239.93% |
| Jun 30, 2021 | 33.81% |
| Mar 31, 2021 | -25.44% |